INSULET CORPORATION (PODD) Free cash flow
- Free cash flow · 12 months (USD): Value $293.70M; Formula and calculation Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30..
- Price / free cash flow · 12 months: Value (m); Formula and calculation Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30..
- Free cash flow yield · 12 months: Value (m); Formula and calculation (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30..
- Free cash flow margin · 12 months: Value 9.62%; Formula and calculation (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30..
Free cash flow
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Free cash flow · 12 months (USD) | $293.70M | Operating cash flow minus capital spending; distinct from the saved levered FCF quote figure. Period ending 2026-06-30. $511.20M − $217.50M ≈ $293.70M |
| Price / free cash flow · 12 months | (m) | Market cap / trailing-year free cash flow; inverse of FCF yield before percent scaling. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow yield · 12 months | (m) | (Operating cash flow − capital spending) / current market cap. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Free cash flow margin · 12 months | 9.62% | (Operating cash flow − capital spending) / revenue. Period ending 2026-06-30. $293.70M ÷ $3.05B × 100 ≈ 9.62% |
| Free cash flow per share · 12 months | (m) | (Trailing-year operating cash flow − capital spending) / reported quarter-end common shares. Period ending 2026-06-30. Calculation unavailable: missing inputs remain (m). |
| Operating cash flow · 12 months | $511.20M | Cash generated by operating activities. Period ending 2026-06-30. |
| Operating cash flow / net income · 12 months | 1.36× | Operating cash flow / net income. Period ending 2026-06-30. $511.20M ÷ $375.30M ≈ 1.36× |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating cash flow | 511.20M USD | Net Cash Provided by (Used in) Operating Activities |
| Capital spending | 217.50M USD | Payments to Acquire Property, Plant, and Equipment |
| Market cap | (m) | |
| Free cash flow | 293.70M USD | Net Cash Provided by (Used in) Operating Activities · Payments to Acquire Property, Plant, and Equipment |
| Revenue | 3.05B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Quarter-end shares | (m) | Common Stock, Shares, Outstanding |
| Net income | 375.30M USD | Net Income (Loss) Attributable to Parent |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Free cash flow | FCF per share | Operating cash flow | Capital spending (USD) | Market cap (USD) | Revenue (USD) | Quarter-end shares (shares) | Net income (USD) | Price / FCF | FCF yield | FCF margin | Cash conversion |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $293.70M | (m) | $511.20M | $217.50M | (m) | $3.05B | (m) | $375.30M | (m) | (m) | 9.62% | 1.36× |
| 2026-03-31 | $415.70M | (m) | $619.30M | $203.60M | (m) | $2.90B | (m) | $302.80M | (m) | (m) | 14.33% | 2.05× |
| 2025-12-31 | $377.70M | (m) | $569.30M | $191.60M | (m) | $2.71B | (m) | $247.10M | (m) | (m) | 13.95% | 2.30× |
| 2025-09-30 | $423.50M | (m) | $533.60M | $110.10M | (m) | $2.52B | (m) | $246.20M | (m) | (m) | 16.79% | 2.17× |
| 2025-06-30 | $405.00M | (m) | $516.20M | $111.20M | (m) | $2.36B | (m) | $236.10M | (m) | (m) | 17.16% | 2.19× |
| 2025-03-31 | $291.40M | (m) | $406.50M | $115.10M | (m) | $2.20B | (m) | $402.20M | (m) | (m) | 13.25% | 1.01× |
| 2024-12-31 | $305.40M | (m) | $430.30M | $124.90M | (m) | $2.07B | (m) | $418.30M | (m) | (m) | 14.74% | 1.03× |
| 2024-09-30 | $227.20M | (m) | $327.80M | $100.60M | (m) | $1.98B | (m) | $420.90M | (m) | (m) | 11.45% | 0.78× |
| 2024-06-30 | $191.30M | (m) | $285.30M | $94.00M | (m) | $1.87B | (m) | $395.30M | (m) | (m) | 10.22% | 0.72× |
| 2024-03-31 | $145.60M | (m) | $232.80M | $87.20M | (m) | $1.88B | (m) | $234.00M | (m) | (m) | 7.75% | 0.99× |
| 2023-12-31 | $70.10M | (m) | $145.70M | $75.60M | (m) | $1.70B | (m) | $206.30M | (m) | (m) | 4.13% | 0.71× |
| 2023-09-30 | $40.50M | (m) | $151.20M | $110.70M | (m) | $1.47B | (m) | $120.00M | (m) | (m) | 2.76% | 1.26× |
| 2023-06-30 | $30.20M | (m) | $151.90M | $121.70M | (m) | $1.32B | (m) | $62.90M | (m) | (m) | 2.29% | 2.41× |
| 2023-03-31 | $12.60M | (m) | $133.20M | $120.60M | (m) | $1.07B | (m) | $600.00K | (m) | (m) | 1.18% | 222.00× |
| 2022-12-31 | $-3.90M | (m) | $119.00M | $122.90M | (m) | $1.06B | (m) | $4.60M | (m) | (m) | -0.37% | 25.87× |
| 2022-09-30 | $-47.50M | (m) | $42.80M | $90.30M | (m) | $1.10B | (m) | $16.80M | (m) | (m) | -4.32% | 2.55× |
| 2022-06-30 | $-126.20M | (m) | $-39.70M | $86.50M | (m) | $1.08B | (m) | $34.60M | (m) | (m) | -11.69% | -1.15× |
| 2022-03-31 | $-138.50M | (m) | $-46.70M | $91.80M | (m) | $1.10B | (m) | $44.60M | (m) | (m) | -12.63% | -1.05× |
| 2021-12-31 | $-180.00M | (m) | $-68.10M | $111.90M | (m) | $1.10B | (m) | $16.80M | (m) | (m) | -16.38% | -4.05× |
| 2021-09-30 | $-156.50M | (m) | $-25.60M | $130.90M | (m) | $1.04B | (m) | $-29.50M | (m) | (m) | -15.09% | 0.87× |
| 2021-06-30 | $-85.70M | (m) | $44.40M | $130.10M | (m) | $995.60M | (m) | $-30.50M | (m) | (m) | -8.61% | -1.46× |
| 2021-03-31 | $-82.50M | (m) | $52.50M | $135.00M | (m) | $958.70M | (m) | $8.90M | (m) | (m) | -8.61% | 5.90× |
| 2020-12-31 | $-45.00M | (m) | $84.00M | $129.00M | (m) | $904.40M | (m) | $6.80M | (m) | (m) | -4.98% | 12.35× |
| 2020-09-30 | $-5.70M | (m) | $131.90M | $137.60M | (m) | $867.70M | (m) | $28.90M | (m) | (m) | -0.66% | 4.56× |
| 2020-06-30 | $-22.70M | (m) | $100.80M | $123.50M | (m) | $825.80M | (m) | $18.10M | (m) | (m) | -2.75% | 5.57× |
| 2020-03-31 | $-57.90M | (m) | $88.30M | $146.20M | (m) | $776.60M | (m) | $5.10M | (m) | (m) | -7.46% | 17.31× |
| 2019-12-31 | $-65.30M | (m) | $98.40M | $163.70M | (m) | $738.20M | (m) | $11.60M | (m) | (m) | -8.85% | 8.48× |
| 2019-09-30 | $-70.18M | (m) | $81.91M | $152.08M | (m) | $693.71M | (m) | $16.52M | (m) | (m) | -10.12% | 4.96× |
| 2019-06-30 | $-100.00M | (m) | $66.57M | $166.57M | (m) | $652.67M | (m) | $17.33M | (m) | (m) | -15.32% | 3.84× |
| 2019-03-31 | $-125.70M | (m) | $46.53M | $172.24M | (m) | $599.80M | (m) | $14.24M | (m) | (m) | -20.96% | 3.27× |
| 2018-12-31 | $-126.45M | (m) | $35.90M | $162.35M | (m) | $563.82M | (m) | $3.29M | (m) | (m) | -22.43% | 10.90× |
| 2018-09-30 | $-129.71M | (m) | $27.26M | $156.97M | (m) | $529.44M | (m) | $-13.46M | (m) | (m) | -24.50% | -2.03× |
| 2018-06-30 | $-93.41M | (m) | $34.68M | $128.09M | (m) | $500.14M | (m) | $-17.35M | (m) | (m) | -18.68% | -2.00× |
| 2018-03-31 | $-28.14M | (m) | $58.78M | $86.92M | (m) | $485.63M | (m) | $-23.42M | (m) | (m) | -5.80% | -2.51× |
| 2017-12-31 | $-36.02M | (m) | $41.21M | $77.23M | (m) | $463.77M | (m) | $-26.83M | (m) | (m) | -7.77% | -1.54× |
| 2017-09-30 | $-11.25M | (m) | $39.48M | $50.72M | (m) | $436.82M | (m) | $-29.09M | (m) | (m) | -2.57% | -1.36× |
| 2017-06-30 | $-36.40M | (m) | $18.88M | $55.28M | (m) | $409.92M | (m) | $-29.94M | (m) | (m) | -8.88% | -0.63× |
| 2017-03-31 | $-40.04M | (m) | $4.59M | $44.63M | (m) | $387.49M | (m) | $-26.38M | (m) | (m) | -10.33% | -0.17× |
| 2016-12-31 | $-6.20M | (m) | $15.91M | $22.11M | (m) | $366.99M | (m) | $-28.88M | (m) | (m) | -1.69% | -0.55× |
| 2016-09-30 | $-45.44M | (m) | $-22.75M | $22.69M | (m) | $347.21M | (m) | $-47.09M | (m) | (m) | -13.09% | 0.48× |
| 2016-06-30 | $-28.60M | (m) | $-16.68M | $11.91M | (m) | $384.07M | (m) | $-62.93M | (m) | (m) | -7.45% | 0.27× |
| 2016-03-31 | $-29.00M | (m) | $-19.58M | $9.42M | (m) | $357.29M | (m) | $-74.17M | (m) | (m) | -8.12% | 0.26× |
| 2015-12-31 | $-23.16M | (m) | $-12.55M | $10.61M | (m) | $324.23M | (m) | $-73.52M | (m) | (m) | -7.14% | 0.17× |
| 2015-09-30 | $891.00K | (m) | $10.65M | $9.76M | (m) | $296.67M | (m) | $-51.59M | (m) | (m) | 0.30% | -0.21× |
| 2015-06-30 | $-3.62M | (m) | $6.73M | $10.34M | (m) | $284.35M | (m) | $-43.51M | (m) | (m) | -1.27% | -0.15× |
| 2015-03-31 | $-7.23M | (m) | $6.45M | $13.68M | (m) | $280.77M | (m) | $-57.19M | (m) | (m) | -2.57% | -0.11× |
| 2014-12-31 | $-2.57M | (m) | $8.92M | $11.49M | (m) | $288.72M | (m) | $-51.50M | (m) | (m) | -0.89% | -0.17× |
| 2014-09-30 | $-10.85M | (m) | $795.00K | $11.64M | (m) | $284.69M | (m) | $-48.60M | (m) | (m) | -3.81% | -0.02× |
| 2014-06-30 | $-10.69M | (m) | $-333.00K | $10.36M | (m) | $270.81M | (m) | $-59.05M | (m) | (m) | -3.95% | 0.01× |
| 2014-03-31 | $-4.86M | (m) | $3.53M | $8.39M | (m) | $258.89M | (m) | $-40.45M | (m) | (m) | -1.88% | -0.09× |
| 2013-12-31 | $-3.96M | (m) | $3.35M | $7.31M | (m) | $247.08M | (m) | $-44.97M | (m) | (m) | -1.60% | -0.07× |
| 2013-09-30 | $-5.30M | (m) | $1.27M | $6.57M | (m) | $236.38M | (m) | $-52.67M | (m) | (m) | -2.24% | -0.02× |
| 2013-06-30 | $-15.31M | (m) | $-5.87M | $9.44M | (m) | $230.03M | (m) | $-43.80M | (m) | (m) | -6.65% | 0.13× |
| 2013-03-31 | $-31.72M | (m) | $-21.36M | $10.36M | (m) | $220.97M | (m) | $-47.75M | (m) | (m) | -14.35% | 0.45× |
| 2012-12-31 | $-40.05M | (m) | $-29.06M | $10.99M | (m) | $211.37M | (m) | $-51.87M | (m) | (m) | -18.95% | 0.56× |
| 2012-09-30 | $-42.35M | (m) | $-31.13M | $11.21M | (m) | $200.73M | (m) | $-56.01M | (m) | (m) | -21.10% | 0.56× |
| 2012-06-30 | $-38.32M | (m) | $-28.52M | $9.80M | (m) | $190.57M | (m) | $-57.16M | (m) | (m) | -20.11% | 0.50× |
| 2012-03-31 | $-36.41M | (m) | $-26.49M | $9.92M | (m) | $171.75M | (m) | $-62.10M | (m) | (m) | -21.20% | 0.43× |
| 2011-12-31 | $-36.57M | (m) | $-25.45M | $11.11M | (m) | $152.25M | (m) | $-57.17M | (m) | (m) | -24.02% | 0.45× |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-03-31 | (m) | (m) | (m) | (m) | (m) | $104.42M | (m) | $-56.52M | (m) | (m) | (m) | (m) |
| 2010-12-31 | $-42.17M | (m) | $-35.63M | $6.55M | (m) | $96.97M | (m) | $-61.16M | (m) | (m) | -43.49% | 0.58× |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $-52.46M | (m) | $-49.32M | $3.14M | (m) | $66.03M | (m) | $-72.34M | (m) | (m) | -79.45% | 0.68× |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |